LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
about
Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host DiseasesGut microbiota and allogeneic transplantationThe role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantationPossible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationThe Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseMouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseThe biology of graft-versus-host disease: experimental systems instructing clinical practice.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.Therapeutic potential of the bactericidal/permeability-increasing protein.The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationCytolytic pathways in haematopoietic stem-cell transplantation.TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.Separating graft-versus-tumor from graft-versus-host reactions.New horizons for the infectious diseases specialist: how gut microflora promote health and disease.Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host diseaseEndotoxin antagonism: conceptual basis and therapeutic potential.Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHDTranslational research efforts in biomarkers and biology of early transplant-related complications.Approaches to design non-covalent inhibitors for human granzyme B (hGrB).Nitric oxide inhibitable isoforms of adenylate cyclase mediate epithelial secretory dysfunction following exposure to ionising radiation.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantationTrans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?Rapid Functional Decline of Activated and Memory Graft-versus-Host-Reactive T Cells Encountering Host Antigens in the Absence of Inflammation.Antigen-presenting cell-derived complement modulates graft-versus-host diseaseCytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation.Immune restoration following hematopoietic stem cell transplantation: an evolving target.GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.The Microbiome and Immune Regulation After Transplantation.Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells
P2860
Q26741220-593E891B-187F-49E1-B57C-CD44D27F8EEBQ26795634-0760B06C-7A9B-4F9A-B224-B386F65CF70EQ26824436-9AED886F-94FA-4999-83DB-C044FFD161A7Q27001015-66E98B60-3955-4091-A0FB-237A00ED0C09Q28066083-4DAD2C56-AD0C-4BE8-9EDD-5E3883DA4D50Q28076264-5C90AAD8-E656-412A-B5AB-B49046DB3687Q33638762-C4D597AF-E820-429B-86F2-777B9B102DC2Q33680743-2FB0323C-4F75-439B-942C-045246CA1C0EQ33835099-9328330D-923D-4E86-A4DA-E6C8749A2A30Q33917175-EF13CF7A-7A39-4688-BB6A-1E304A3D2A56Q33944262-D685D6CB-9A3C-4983-9DC3-A5B1051C51ABQ34038286-6F864FBE-C0FE-4692-AFA6-C6FFC1E23438Q34167845-63341502-0527-4008-B565-DE409A5C648DQ34265880-8F417A44-9B05-49FC-99A6-C064065BBCD1Q34519111-8E0DE834-4E4C-4939-8A15-82FCEE90BC6CQ34577694-58BCF41C-5399-4851-AD1B-8F739A32B797Q34618829-E0FF680F-8E76-4B5D-BF16-8FC57604BBC3Q34632083-AD70C852-2DA4-4CD2-9D1D-5967CDAAD5C0Q34734027-2995A0A9-0656-4953-98E1-F5833DD7D832Q34769849-2352030E-AFA0-4423-A1D8-1245041C0E6DQ34780670-2AA59FAD-5A09-4A52-B9DA-3339B9CCF0D6Q34791351-4D8F8295-1DA5-4470-B8F6-B90B317D8E89Q34837530-3A9EFE89-A660-497E-AC74-C9429619DB47Q35007600-1FBC525D-FF74-40D5-AD64-BF252D9C800CQ35022269-34469F28-3052-4829-8637-F95D727632DFQ35084400-D1D6B8F4-0990-4FE4-B3B3-7B265176D5E4Q35185329-5A7044A6-7EEC-4146-9D92-A98D93FC291BQ35296702-1899B53F-62A5-4D65-A38C-7B342F626AF1Q35598243-0F81E9E2-5A37-47DA-9ED6-381B5374CF3AQ35694784-929F5944-DEC1-467D-8EC9-73D45015C1A0Q35799360-2722AC5C-7208-46CB-8210-D36BA7C00EC8Q35849134-7DB4001A-42CA-4CF0-8686-4F24A9F78899Q35858408-6036D499-7C07-495F-B0D9-A1DB91A70B93Q35864495-CF510145-90E6-4606-B618-F87989892146Q36005386-BBEB4AD7-F540-41F7-B31B-2D91CAA23C01Q36006379-B4A83BB9-F381-486E-871A-C5F5ABC8AC2AQ36075296-9AA309BB-6470-449B-B0D4-2E78B7850341Q36091313-9110EF90-2723-4EEB-B0FE-1F6C5D060768Q36102645-5F28D7D1-CC90-47D5-B6EE-927ABC40858AQ36107077-F45A3F34-3CD4-487D-A3E5-5FB6C992F796
P2860
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@ast
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@en
type
label
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@ast
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@en
prefLabel
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@ast
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@en
P2093
P2860
P356
P1476
LPS antagonism reduces graft-v ...... l bone marrow transplantation.
@en
P2093
D P Rossignol
J L Ferrara
J M Crawford
P2860
P304
P356
10.1172/JCI12156
P407
P577
2001-06-01T00:00:00Z